Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-05-27 19:26 CEST (UTC+2h)

intra-subject variability in a fixed sequence 2 period design [General Sta­tis­tics]

posted by martin - Austria, 2017-03-28 15:25  - Posting: # 17194
Views: 438

Dear all,

I have a question regarding estimating intra-subject variability in a fixed sequence 2 period design (i.e. A followed by B).

This could be analyzed by a paired t-test or mixed model whereas the latter has some benefit in case of missing values in one period assuming that missing values are missing at random and I will focus therefore on the mixed model approach (although probably challenged by some regulatory agencies for that reason).

With the mixed model approach you model the subject as random factor and treatment as fixed and you get an estimate for the between subject variability and the residual error.

My question: on which premises can the residual error obtained from the mixed effects model to be interpreted as within subject variability?

Best regards & looking forward to an interesting discussion


Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
16,926 Posts in 3,627 Threads, 1,029 registered users;
14 users online (0 registered, 14 guests).

EMEA. The European Medicines Evaluation Agency.
The drug regulatory agency of the European Union.
A statistician-free zone.    Stephen Senn

BEBAC Ing. Helmut Schütz